Definition
Virginiamycin is a commercial mixture of two related streptogramin antibiotics, designated streptogramin A (virginiamycin M1) and streptogramin B (virginiamycin S1). It exhibits bacteriostatic activity against a range of Gram‑positive bacteria and is primarily employed as a growth promoter and therapeutic agent in veterinary medicine.
Overview
Developed by Eli Lilly and Company in the 1960s, Virginiamycin has been used in livestock production, particularly in swine and poultry, to improve feed efficiency and control subclinical infections. Its mode of action involves synergistic inhibition of bacterial protein synthesis: the streptogramin A component binds to the peptidyl‑transferase region of the 50S ribosomal subunit, while the streptogramin B component binds to a distinct site on the same subunit, together producing a potent bacteriostatic effect. Due to concerns about antimicrobial resistance, many countries have restricted or withdrawn its use as a growth promoter, though therapeutic applications under veterinary prescription remain permitted in some jurisdictions.
Etymology/Origin
The name “Virginiamycin” derives from “Virginia,” the U.S. state where the producing organism Streptomyces virginiae (now Streptomyces pristinaespiralis) was originally isolated, combined with the suffix “‑mycin,” commonly used for antibiotics produced by actinomycetes.
Characteristics
| Property | Details |
|---|---|
| Chemical class | Streptogramin antibiotics (combination of streptogramin A and B) |
| Molecular formula | Streptogramin A (C₃₆H₆₈N₁₂O₁₃), Streptogramin B (C₃₄H₆₀N₁₀O₁₁) |
| Mechanism of action | Synergistic inhibition of bacterial protein synthesis at the 50S ribosomal subunit |
| Spectrum of activity | Primarily Gram‑positive organisms, including Staphylococcus spp., Streptococcus spp., and certain Enterococcus spp. |
| Formulations | Typically supplied as a powdered feed additive; also available for parenteral or oral veterinary administration |
| Regulatory status | Banned as a growth promoter in the European Union (2006) and the United States (2008). Permitted for limited veterinary therapeutic use in some countries under strict controls. |
| Resistance concerns | Use can select for resistance genes (e.g., vga and erm families) that may be transferable to human pathogens. |
Related Topics
- Streptogramin antibiotics – a class of antibiotics that includes quinupristin/dalfopristin (Synercid) used in human medicine.
- Antimicrobial growth promoters – substances added to animal feed to improve growth rates, many of which have faced regulatory restrictions.
- Antibiotic resistance – the broader public‑health issue concerning the emergence and spread of resistant bacterial strains.
- Veterinary pharmacology – the study and application of drugs used in animal health.
- Streptomyces pristinaespiralis – the microbial species originally identified as the producer of Virginiamycin.